1^st Speaker

Bariatric Surgery and Cannabis Use - Current Perspectives

Daniela B. Rakocevic, M.D., M.S.

2^nd Speaker

Disability and Return to Work for Patients with Psychiatric Disorders

Nicholas (Nick) D. Allen, M.D.

Introduction

1^st Speaker

Dr. Daniela Rakocevic graduated summa cum laude from the University of Belgrade Medical School, where she also received her Master of Science degree in Psychiatry and completed a residency in Adult Psychiatry. After transitioning her career to United States, she completed her Psychiatry residency at Mayo Clinic serving as Administrative Chief Resident. She is currently a fellow in Addiction Psychiatry and an Instructor in Psychiatry at Mayo Clinic School of Medicine. Dr. Rakocevic has a special interest in medical education and the overlap between addiction and consultation-liaison psychiatry. She is the recipient of several national awards for teaching/education, addiction psychiatry and addiction medicine.

Introduction

2nd Speaker

Dr. Allen completed undergraduate and medical school at the University of Kansas. He is currently a consult-liaison psychiatry fellow at Mayo Clinic.  He enjoys spending time with his family and being outdoors as often as possible.

​​
Learning Objectives
1st Speaker

1. Review the role of an Addiction Psychiatrist in assessing candidacy for bariatric surgery.
2. Describe the current state of research on cannabis use in bariatric surgery candidates/recipients.

Learning Objectives
2nd Speaker

1. Recognize two different approaches taken by physicians when assessing and treating depressed patients on sick leave.
2. Identify evidence based return to work interventions for patients with psychiatric disorders. 

Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA

The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP).  The APA CEP Office maintains responsibility for the contents of the programs. 

This activity is approved for a maximum of 1.0 credits.  Credit is awarded only for actual instructional time.

Archived webcast available at: Psychiatry & Psychology Video Library

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010

2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.

-or-

Click the START button on that session page.

3) Evaluation must be completed within 2 weeks.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

Disclosure Summary

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, MD, Mayo Clinic              

Grant Support - Assurex Health, Mayo Foundation, Myriad, NIAAA, NIMH, Pfizer
Consultant - Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Mitsubishi Tanabe Pharma Coporation, Myriad, Neuralstem Inc., Otsuka American Pharmaceutical, Sunovion, Takeda, Teva Pharmaceuticals 

No relevant financial relationship(s) with industry:

Joshua Baruth, MD, Julia Benjamin, PhD, Ewa Bieber, MD, Deniz Doruk Camsari, MD., Melissa Goldschmidt, APRN, CNP, Ashli McLaughlin, Sohail Mohammad, MBBS, MPH, Charlene Nelson, Daniela Rakocevic, MD, Kate Zelic, PhD

Speakers: 
Daniela Rakocevic, M.D., M.S.
Nicholas Allen, M.D.
 

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.